Risk of anomalies as a function of level of elevated maternal serum alpha-fetoprotein.
Most neural tube defects risks are not actual but mathematical extrapolations. We sought to evaluate this risk and to compare actual performance. This was a retrospective study of a referral population with elevated maternal serum alpha-fetoprotein results between 1987 and 1992. Ultrasonography results, delivery records, and autopsy results were compared with entry levels of maternal serum alpha-fetoprotein, and the percentage of fetal anomalies detected in this study was evaluated. A total of 773 patients with elevated maternal serum alpha-fetoprotein levels were evaluated. There was a progressive increase in the incidence of anomalies as a direct function of the level of the maternal serum AFP, varying from 3.4% at a level of 2.5 to 40.3% at a level > 7.0. Data from this study support the correlation of maternal serum AFP levels with the risk of neural tube defect and ventral wall defects.